Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
6,670.00
-100.00 (-1.48%)
At close: Feb 13, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 93.62 billion as of February 13, 2026. Its market cap has decreased by -8.00% in one year.
Market Cap
93.62B
Enterprise Value
157.15B
Revenue
201.59B
Ranking
n/a
PE Ratio
8.61
Stock Price
6,670.00
Market Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 93.62B, an increase of 618.35%. That is a compound annual growth rate of 8.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 93.62B | 1.52% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WITHUS PHARMACEUTICAL Co.,LTD. | 117.50B |
| Pharos iBio | 112.24B |
| BL Pharmtech | 111.52B |
| H.PIO | 99.27B |
| Sam-A Pharm. | 98.45B |
| Ahn-Gook Pharmaceutical | 98.42B |
| Sinsin Pharmaceutical | 91.48B |
| Hwail Pharmaceutical | 90.95B |